Figures
Philadelphia Life Sciences Figures Q1 2026
Long-term outlook positive despite occupancy losses to start the year
April 27, 2026 2 Minute Read
Looking for a PDF of this content?
- Two significant leases totaling more than 360,000 sq. ft. accounted for all of the leasing activity in Q1 2026.
- Philadelphia's biotech sector saw significant early-year investment in 2026, including notable funding rounds for Penn-BioNTech and Alveus Therapeutics, potentially indicating a positive shift in investor outlook.
- This quarter, a significant number of blocks became available at Discover Labs in King of Prussia, driving nearly all of the negative absorption to start the year.